Azenta, Inc.·Healthcare
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Healthcare
Medical - Instruments & Supplies
3,000
1995-02-02
1.47

BURLINGTON, Mass., April 7, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the appointment of Trey Martin as President of its Multiomics business, effective April 6, 2026.

Assenagon Asset Management S.A. increased its position in shares of Azenta, Inc. (NASDAQ: AZTA) by 249.4% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 96,602 shares of the company's stock after purchasing an additional 68,955 shares during the period.

Azenta, Inc. trades near $20, with operating assets valued at just 0.5x sales and a robust net cash position around $600 million. Recent AZTA developments include the UK Biocentre acquisition and B Medical Systems divestiture, with the latter removing a key earnings drag. Despite a soft Q1 and margin pressure, Azenta maintains full-year guidance, supported by remediation efforts and interest income.

Congress Asset Management Co. purchased a new stake in shares of Azenta, Inc. (NASDAQ: AZTA) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,285,472 shares of the company's stock, valued at approximately $42,755,000. Congress Asset Management Co.

Talkspace (NASDAQ: TALK - Get Free Report) and Azenta (NASDAQ: AZTA - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership. Analyst Recommendations This is a summary of current recommendations

Azenta, Inc. (AZTA) M&A Call Transcript